College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Foodborne Pathog Dis. 2021 Feb;18(2):85-96. doi: 10.1089/fpd.2020.2835. Epub 2020 Oct 2.
Tylosin phosphate (TYL) is administered to more than 50% of U.S. beef cattle to reduce the incidence of liver abscesses but may increase the risk of macrolide-lincosamide-streptogramin-resistant bacteria disseminating from the feedlot. Limited evidence has been collected to understand how TYL affects the proportion of resistant bacteria in cattle or the feedlot environment. We created a mathematical model to investigate the effects of TYL administration on dynamics and examined preharvest strategies to mitigate the impact of TYL administration on resistance. The model simulated the physiological pharmacokinetics of orally administered TYL and estimated the pharmacodynamic effects of TYL on populations of resistant and susceptible within the cattle large intestine, feedlot pen, water trough, and feed bunk. The model parameters' population distributions were based on the available literature; 1000 Monte Carlo simulations were performed to estimate the likely distribution of outcomes. At the end of the simulated treatment period, the median estimated proportion of macrolide-resistant enterococci was only 1 percentage point higher within treated cattle compared with cattle not fed TYL, in part because the TYL concentrations in the large intestine were substantially lower than the enterococci minimum inhibitory concentrations. However, 25% of the simulated cattle had a >10 percentage point increase in the proportion of resistant enterococci associated with TYL administration, termed the TYL effect. The model predicts withdrawing TYL treatment and moving cattle to an antimicrobial-free terminal pen with a low prevalence of resistant environmental enterococci for as few as 6 days could reduce the TYL effect by up to 14 percentage points. Additional investigation of the importance of this subset of cattle to the overall risk of resistance transmission from feedlots will aid in the interpretation and implementation of resistance mitigation strategies.
磷酸泰乐菌素(TYL)被用于超过 50%的美国肉牛,以降低肝脓肿的发病率,但可能会增加大环内酯类-林可酰胺类-链阳性菌素耐药菌从饲养场传播的风险。目前已经收集了有限的证据来了解 TYL 如何影响牛或饲养场环境中耐药菌的比例。我们创建了一个数学模型来研究 TYL 给药对细菌动力学的影响,并研究了在收获前减轻 TYL 给药对耐药性影响的策略。该模型模拟了口服 TYL 的生理药代动力学,并估计了 TYL 对牛大肠、饲养场畜栏、饮水槽和饲料槽中耐药和敏感细菌群体的药效学影响。模型参数的种群分布基于现有文献;进行了 1000 次蒙特卡罗模拟,以估计结果的可能分布。在模拟治疗期结束时,与未服用 TYL 的牛相比,接受治疗的牛中耐大环内酯类肠球菌的估计比例仅高出 1 个百分点,部分原因是大肠中 TYL 的浓度远低于肠球菌的最低抑菌浓度。然而,25%的模拟牛的耐肠球菌比例因 TYL 给药而增加了超过 10 个百分点,这被称为 TYL 效应。该模型预测,停止 TYL 治疗并将牛转移到一个抗菌剂自由的终端畜栏,该畜栏中耐药环境肠球菌的流行率较低,仅需 6 天即可将 TYL 效应降低多达 14 个百分点。对这部分牛对饲料场耐药菌传播总体风险的重要性进行进一步调查,将有助于对耐药性缓解策略的解释和实施。